| Esophageal Squamous Cell Carcinoma studied in …STUDIED_INderived200 of 555show all (up to 200) |
|---|
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07733180Phase 2 · recruiting A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07757906NA · active not recruiting Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal Dissection · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836049Phase 2 · not yet recruiting PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06329869Phase 2 · recruiting Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830355Phase 2 · not yet recruiting Immunotherapy Plus Anlotinib After Surgery for Esophageal Squamous Cell Cancer With Residual Tumor and Positive Lymph Nodes · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07147361active not recruiting Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05043688Phase 3 · active not recruiting Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC. · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06780111Phase 1/Phase 2 · recruiting Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07109726Phase 1/Phase 2 · recruiting A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07405151Phase 1/Phase 2 · recruiting A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F) · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07751341Phase 2 · recruiting A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822906not yet recruiting Risk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, and Surgery · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823270Phase 2 · not yet recruiting Neoadjuvant Sacituzumab Tirumotecan Plus Toripalimab in Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04543617Phase 3 · completed A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799274Phase 1 · active not recruiting Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140500Phase 1/Phase 2 · active not recruiting Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714538recruiting Breath Research Narrow Validation for Gastrointestinal Cancer Detection · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01142388Phase 2 · active not recruiting Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07811752Phase 2 · recruiting Sacituzumab Govitecan Combined With Tislelizumab for Locally Advanced/Metastatic Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07090499Phase 1 · recruiting A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07602842Phase 1/Phase 2 · recruiting A Study of IDP-001 in Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05319730Phase 1/Phase 2 · recruiting A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07799077Phase 2 · not yet recruiting Paclitaxel Polymeric Micelles and Cisplatin Plus Sintilimab as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05945823Phase 2 · active not recruiting Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796113Phase 2 · recruiting Adebrelimab With Famitinib and Chemotherapy as Neoadjuvant Therapy for ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07700667Phase 2 · recruiting SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07787273Phase 2 · recruiting Interferon Gamma Plus Camrelizumab as Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03801876Phase 3 · active not recruiting Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Thoracic Esophagus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084481Phase 1 · recruiting Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07554521Phase 2 · recruiting A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04949256Phase 3 · terminated Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014). · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778056not yet recruiting Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769658not yet recruiting Standardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769866NA · not yet recruiting Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04221893NA · recruiting Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07488624completed Survival Prediction After Neoadjuvant Chemoimmunotherapy and Esophagectomy for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06242470Phase 1 · recruiting A Study of MGC026 in Participants With Advanced Solid Tumors · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06596954NA · recruiting Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07751055Phase 2 · recruiting Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06644781Phase 3 · recruiting A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07745322active not recruiting Spatial MSC Index for Predicting Anti-PD-1 Efficacy in Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06281886Phase 2 · completed Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04460937Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07629817Phase 3 · recruiting Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05028725NA · recruiting Novel Strategy for Early Detection of Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06304974Phase 3 · active not recruiting A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04210115Phase 3 · completed Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05208762Phase 1 · recruiting A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07721103Phase 2 · not yet recruiting Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05078047Phase 3 · active not recruiting Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07711470Phase 2 · active not recruiting Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07487896Phase 3 · recruiting A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line Therapy · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07554456Phase 2/Phase 3 · recruiting A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686926Phase 2 · not yet recruiting Becotatug Vedotin Plus Tislelizumab and Low-Dose Lenvatinib for Advanced Esophageal Squamous Cell Carcinoma, Phase II · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705412completed Postoperative Radiotherapy and Lymph Node Dissection After Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03712566active not recruiting Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07701681Phase 2 · not yet recruiting Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07702253active not recruiting O-GlcNAcylation Induced HMGB1 Signalling · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06490003recruiting Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07697859recruiting PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07697898not yet recruiting TDLN-Guided Lymphadenectomy After Neoadjuvant Immunochemotherapy for ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07699185Phase 2 · recruiting Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07697040Phase 1 · not yet recruiting Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03114319Phase 1 · terminated Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06165380Phase 2 · active not recruiting Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224750recruiting A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07403136Phase 2 · recruiting Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07688291Phase 2 · not yet recruiting A Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in Advanced Esophageal Squamous Cell Carcinoma After Failure of Prior ICI Plus Platinum-Based Chemotherapy · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04389632Phase 1 · recruiting A Study of Sigvotatug Vedotin in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07682376Phase 2 · active not recruiting Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07678580Phase 2 · not yet recruiting Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06747585Phase 1/Phase 2 · recruiting A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929392Phase 2 · active not recruiting Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06545331Phase 1 · recruiting Study of XB010 in Subjects With Solid Tumors · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06971848NA · recruiting Evaluation of Skin Tests in Biotherapy Allergies · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07339488Phase 2 · recruiting Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07503808Phase 1 · recruiting A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07653451Phase 2/Phase 3 · not yet recruiting Precision Medicine for Immunotherapy-Resistant Advanced Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07284186Phase 1 · recruiting First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218003Phase 1 · enrolling by invitation A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07638436Phase 2 · recruiting Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06265285Phase 2 · recruiting Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623642Phase 2 · not yet recruiting A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors. · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06339619Phase 2 · recruiting Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621601Phase 3 · not yet recruiting A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07618910Phase 2 · not yet recruiting Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06010303Phase 2 · completed A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07452601Phase 2 · recruiting Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05910827Phase 1/Phase 2 · recruiting A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07605663active not recruiting an AI-Driven Four-Tier Invasion Depth Classification for Early Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07205731Phase 2 · recruiting Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07595770Phase 2 · recruiting Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04550260Phase 3 · active not recruiting Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07085091Phase 1 · recruiting A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07581236NA · completed A Single-center, Single-arm Clinical Study Evaluating the Short-term Efficacy of Inflatable Mediastinoscopic-assisted Transhiatal Laparoscopic Esophagectomy for the Radical Resection of Thoracic Esophageal Cancer · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07567716enrolling by invitation Infiltration Pattern of Locally Advanced ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07559045Phase 2 · recruiting Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06401447NA · active not recruiting TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07244978Phase 2 · not yet recruiting Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07463573Phase 3 · recruiting QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07549100recruiting Efficacy and Safety of Tislelizumab Plus Chemotherapy as Conversion Therapy in Unresectable Locally Advanced ESCC · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07484724Phase 2 · recruiting A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07519486Phase 2 · recruiting Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07530094Phase 2 · recruiting Short-Course Definitive Chemoradiotherapy Combined With Adjuvant or Concurrent Plus Adjuvant Camrelizumab for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06885814Phase 2 · recruiting Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03957590Phase 3 · completed A Study to Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06504615active not recruiting Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06654297Phase 1 · active not recruiting Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07505186Phase 2 · not yet recruiting Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04785820Phase 2 · completed A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189871Phase 1/Phase 2 · recruiting 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07481058Phase 2 · recruiting KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07482774not yet recruiting Tumor Microenvironment Changes After Neoadjuvant Chemo-Immunotherapy in Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07469241Phase 2 · not yet recruiting Study of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caicinoma. · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07457528Phase 2 · recruiting Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03322267Phase 2 · completed Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07446335Phase 3 · not yet recruiting A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07039162Phase 2 · recruiting Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07435454Phase 2 · recruiting Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07437898Phase 2 · recruiting Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04868877Phase 1/Phase 2 · active not recruiting Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05312372Phase 1/Phase 2 · withdrawn S095033 in Combination With Paclitaxel as 2nd- or 3rd-line Treatment in Participants With Advanced or Metastatic ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05462873Phase 1 · terminated A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07403435Phase 2 · not yet recruiting Short-course Radiotherapy Combined With Serplulimab and Chemotherapy as Neoadjuvant Treatment for Resectable ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05142709completed Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC. · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07385001Phase 1/Phase 2 · recruiting A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05621707Phase 2 · active not recruiting Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06560645Phase 1 · terminated A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06952621Phase 3 · not yet recruiting Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07376876Phase 2 · not yet recruiting Indocyanine Green-guided Omental Shield Anastomosis for Cervical Esophagogastric Anastomosis in Minimally Invasive McKeown Esophagectomy · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04290806recruiting Registry Platform Gastric/Esophageal Cancer (SAPHIR) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07363629NA · completed Impact of Preserving Versus Ligating the Right Gastric Artery on Anastomotic Outcomes After McKeown Esophagectomy: A Randomized Controlled Trial · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978193Phase 2 · recruiting Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07359417Phase 1 · recruiting MR-Guided Radiotherapy Dose Escalation Trial for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07353541not yet recruiting Standardized Management of Esophageal Fistula in Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07343869not yet recruiting Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04229459Phase 2 · active not recruiting Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients. · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07317609Phase 1 · recruiting Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07312578Phase 2 · enrolling by invitation Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04045496Phase 1 · completed A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05342636Phase 1/Phase 2 · completed A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07290010Phase 2 · recruiting The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06549816Phase 1 · completed A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07272291Phase 2 · not yet recruiting A Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07266493Phase 2 · recruiting Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05659251Phase 2 · active not recruiting Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06576973Phase 2 · recruiting Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04974047Phase 2 · completed Study of Tislelizumab in Participants With Resectable Esophageal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07251062Phase 2/Phase 3 · not yet recruiting A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma. · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07246330Phase 3 · not yet recruiting Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05189730Phase 2 · active not recruiting Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07236320NA · completed Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06912074Phase 2 · recruiting Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07086469Phase 2 · recruiting Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05563766Phase 2 · recruiting A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04272034Phase 1 · terminated Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06192212completed PPIO-005 The Relationship Between Different Nutritional Pathways and Tumor Outcomes After Minimally Invasive Esophagectomy · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07203898Phase 1 · not yet recruiting A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma. · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07201571completed A Retrospective Cohort Study of Patients Who Underwent Curative-intent Esophagectomy for ESCC at a Tertiary Referral Center in South Korea · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04000529Phase 1 · terminated Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06333665completed PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05022654Phase 2 · active not recruiting SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma. · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05104567Phase 2 · completed A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07188103Phase 2 · recruiting Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07181850completed Predicting Pathological Complete Response in Esophageal Squamous Cell Carcinoma Using a Multimodal Model Integrating Clinical, Radiomics, and Deep Learning Features · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06601309Phase 2 · recruiting Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06247956Phase 2 · active not recruiting Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07152535not yet recruiting Multi-omics Monitoring of Dynamic Evolution in Esophageal Squamous Cell Carcinoma: PKU-ESCC-Monitor · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07152678Phase 2 · recruiting Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06509568Phase 2 · recruiting Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial） · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06420908NA · withdrawn Adebrelimab Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07142421Phase 2 · active not recruiting A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05880082Phase 2 · completed PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03708328Phase 1 · completed A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07128693Phase 2 · not yet recruiting A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06356688Phase 2 · recruiting A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07112833Phase 2 · not yet recruiting A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03320629Phase 2 · terminated A Study of Apatinib Plus Radiotherapy and S-1 for Treatment of Refractory or Metastatic Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03783442Phase 3 · completed A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07088354recruiting Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03797625Phase 2 · completed Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07080437recruiting An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06020885Phase 1 · active not recruiting Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study. · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07074535active not recruiting CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05834543Phase 1/Phase 2 · terminated Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07067450NA · not yet recruiting Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242199Phase 1 · completed Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07049185Phase 2 · not yet recruiting QL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01351103Phase 1 · completed A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands · condition mapped ALIAS · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05461794Phase 2 · terminated Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04548440Phase 2 · completed Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07016724Phase 2 · recruiting Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07016737Phase 3 · enrolling by invitation Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06446726Phase 2 · recruiting Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914443Phase 1 · completed A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma · condition mapped CURATED_BROADER · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06988956Phase 2 · recruiting Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04328948Phase 3 · recruiting A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCC · condition mapped ONTOLOGY_EXACT · 555 trials mapped (246 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |